Personal and Home Care Products
Medical Devices
C&K Testing
Carbon Neutrality
On December 5, 2023, the European Union Scientific Committee on Consumer Safety (SCCS) published the preliminary opinion(SCCS/1661/23) on Titanium Dioxide (TiO2). The deadline for comments is set for 6 February 2024.
On December 14, 2023, the Taiwanese Ministry of Health and Welfare published a notice on the draft amendment of the List of Ingredients Prohibited in Cosmetic Products to commence a period of public comments. The new amendment will come into effect on July 1, 2024. For any comments or suggestions, please submit them within 60 days from the day following the publication of the notice.
FDA Direct is a U.S. Food and Drug Administration's web-based and free structured product labeling (SPL) authoring tool. Previously CDER Direct, FDA Direct now includes CDER Direct and Cosmetics Direct. Users can create separate accounts, depending on drugs or u乐娱乐国际老虎机s submissions, or a single account that includes both CDER Direct submissions as well as Cosmetics Direct submissions.
Since the implementation of CSAR, according to data from the National Medical Products Administration (NMPA), as shown in Figure 1, in 2021, 6 u乐娱乐国际老虎机s obtained NMPA numbers, of which 4 were for domestically produced u乐娱乐国际老虎机s and 2 for imported u乐娱乐国际老虎机 ingredients. In 2022, 42 u乐娱乐国际老虎机s obtained NMPA numbers, with 25 being domestically produced and 17 being imported. As of December 15, 2023, 60 u乐娱乐国际老虎机s have obtained NMPA numbers, with 46 being domestically produced and 14 being imported.
Since the publication of the Cosmetics Supervision and Administration Regulations (CSAR, State Order No. 727) on June 29, 2020, a series of supporting regulations have also been introduced. Included among all the supporting regulations are those relating to the u乐娱乐国际老虎机 and u乐娱乐国际老虎机 of u乐娱乐国际老虎机s in China, namely the: Measures for the Administration of Cosmetic Registration and Filing; Provisions on the Administration of New Cosmetic Ingredients Registration (hereafter the Provisions); and Filing Data and Technical Guidelines for Cosmetics Safety Assessment.
不朽情缘试玩网址 is to hold a free webinar on the Lau乐娱乐国际老虎机 Regulatory Requirements for New Cosmetic Ingredients in China on December 14 and 21. This webinar aims to introduce the lau乐娱乐国际老虎机 regulatory system and compliance requirements for new u乐娱乐国际老虎机s ingredients in China, to help enterprises successfully complete the u乐娱乐国际老虎机 of new u乐娱乐国际老虎机s ingredients. This webinar is available in Chinese, English and Japanese.
En Chine, la sécurité des ingrédients cosmétiques est réglementée par la NMPA (Administration Nationale des Produits Médicaux) conformément au CSAR (Règlement sur la Supervision et l'Administration des Produits Cosmétiques). Un ingrédient est considéré comme "nouveau" s'il ne figure pas dans l'IECIC 2021 (Inventaire des Ingrédients Cosmétiques Existants en Chine). Les ingrédients existants en Chine doivent être répertoriés dans l'IECIC 2021, et leurs données de sécurité doivent être rapportées à la NMPA via la plateforme d'information de sécurité des ingrédients cosmétiques.
不朽情缘试玩网址 is to hold a free webinar regarding the New Filing Requirements of Toothpaste in China from December 11 to 12. This webinar aims to introduce the lau乐娱乐国际老虎机 regulatory requirements of u乐娱乐国际老虎机 u乐娱乐国际老虎机 to enterprises and assist enterprises in preparing for u乐娱乐国际老虎机 regulatory compliance. This webinar is available in Chinese, English, Japanese and Korean.
Since January 1, 2024, the safety information of all raw materials should be provided when applying for the u乐娱乐国际老虎机 and u乐娱乐国际老虎机 of u乐娱乐国际老虎机s in China. Besides, the NMPA has issued some new requirements regarding the management of safety info of u乐娱乐国际老虎机 ingredients including annex 14 and NMPA code.u乐娱乐国际老虎机will hold a free webinar regarding Lau乐娱乐国际老虎机 Update of Cosmetic Ingredient Safety Info Requirements in China on December 8, 2023. This webinar aims at assisting enterprises successfully complying with the new requirements and reducing the communication costs between upstream and downstream suppliers.
On November 9, 2023, the European Union Scientific Committee on Consumer Safety (SCCS) published the preliminary opinion(SCCS/1658/23) on Hexyl Salicylate (CAS/EC No. 6259-76-3/228-408-6). The deadline for comments was set for 12 January 2024.